Patrick Frayssinet

World Vaccine Congress Washington Speaker Interview: Dr Patrick Frayssinet

|| Dr Patrick Frayssinet, R&D Director, URODELIA We have interviewed a few of the speakers from World Vaccine Congress Washington, taking place on 10-12 April 2017 in Grand Hyatt Washington. This is the 1st of the interview series, stay connected for more. Q1: The most promise opportunities in the veterinary vaccines space are? A: One of the most promise opportunities …

ViE Awards 2016 – Voting is now open!

After weeks of voting and over 1000 nominations collected, we are happy to announce the highly nominated companies in each category as voted by you and your peers for the 9th annual Vaccine Industry Excellence (ViE) Awards in the following categories Best Clinical Trial Site AND Network Best Contract Research Organization Best Contract Manufacturing Organization Best Production/Process Development  Best Academic Research Team …

Over 600 Vaccine executives confirmed!

In terms of the attendees you will meet at the World Vaccine Congress Washington next month, with weeks to go the event is tracking well ahead of this same point last year. In fact we are estimating a growth in numbers by about 25% overall bringing well over 600 leading vaccine executives to the congress. This means by attending you …

World Vaccine Congress 2015: Industry Insights

The World Vaccine Congress  is the  premier event in the vaccine calendar. It is the place where the vaccine industry meets to discuss scientific and commercial issues around vaccine research, development, manufacture and distribution. With only seven weeks to go till the event, we’re getting pretty excited and we hope you are too!  We’ve been in touch with a few of our …

Advaxis Secures $23 Million Financing

Last week, Advaxis, Inc. (a clinical-stage biotechnology company developing cancer immunotherapies on its proprietary Lm-LLO platform technology), announced that a combined $23 million of purchase agreements was raised, worth approximately 3.1 million shares, at a price of $7.50 per share from several institutional investors. The investors include Adage Capital Management, L.P. Broadfin Capital LLC, Sectoral Asset Management, Cormorant Asset Management and …

World Vaccine Congress Washington 2015

Download: ‘Vaccine Insights’ eBook, interviews with the leaders of the vaccine industry

The world of vaccine development is changing. Personalised medicine is making huge waves in the industry, and from this we have seen the rise of therapeutic vaccines for diseases such as cancer. Alongside this, the Ebola crisis has caused all stakeholders to re-evaluate the processes for research and manufacture of vaccines to ensure that they can roll them out as …

Brochure Available for the World Vaccine Congress

1 Event, 7 Conferences at the World Vaccine Congress 2015 The World Vaccine Congress is back for it’s 15th year on April 7-9 in Washington. With over 250 people already signed up to attend, ranging from pharma and biotech, to non-profits and governmental departments, it is set to be another great year. The event has grown for 2015. Not only …